Price
No data yet.
Social Signal Score
Analyst Ratings
13 analystsRevenue
$237.78M+242.83%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Russell J. Low
- Sector
- Technology
- Industry
- Semiconductors
- Employees
- 1,465
- Beta
- 1.89
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 6.69
Financials
Revenue
$237.78M+242.8%Net Income
$37.76M+852.3%EBITDA
$42.46M+512.7%Free Cash Flow
$37.72M+849.8%EPS (diluted)
$1.21+830.8%Shares Outstanding (diluted)
31.11M-1.1%Operating Expenses
$70.08MCash & Debt
$472.36MReturn of Capital
$0.00Revenue by Segment (annual)
$839.05MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $839.05M | $120.24M | $3.81 |
| 2024 | $1.02B | $200.99M | $6.17 |
| 2023 | $1.13B | $246.26M | $7.52 |
| 2022 | $920.00M | $183.08M | $5.54 |
| 2021 | $662.43M | $98.65M | $2.94 |
| 2020 | $474.56M | $49.98M | $1.50 |
| 2019 | $342.96M | $17.03M | $0.52 |
| 2018 | $442.57M | $45.88M | $1.35 |
| 2017 | $410.56M | $126.96M | $4.11 |
| 2016 | $266.98M | $11.00M | $0.38 |
| 2015 | $301.50M | $14.68M | $0.52 |
| 2014 | $203.05M | $-11.27M | $-0.40 |
| 2013 | $195.63M | $-17.14M | $-0.64 |
| 2012 | $203.38M | $-34.03M | $-1.28 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $5.60
- Implied price
- $117.50
- Return from $90.26
- 5.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $58.42 — -35.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| -2.0% | -10.6% | -7.2% | -4.3% | -1.8% | 0.6% |
| 3.0% | -6.0% | -2.5% | 0.5% | 3.3% | 5.7% |
| 8.0% | -1.4% | 2.2% | 5.4% | 8.3% | 10.9% |
| 13.0% | 3.1% | 6.9% | 10.3% | 13.3% | 16.0% |
| 18.0% | 7.7% | 11.7% | 15.2% | 18.3% | 21.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
60+100.00%Social Signal Score
Mentions (23)
- Newsseekingalpha.com·4d ago·Positive
Axcelis Technologies Q3: Seems To Be A Good Entry Point (Rating Upgrade) I upgrade Axcelis Technologies to "Buy" since AI fears have driven an exaggerated sell-off despite limited direct data-center exposure. ACLS trades 40% below my $136 fair value estimate, though projected revenue growth may include Veeco, and long-term margin improvement looks ambitious. Q4 revenue guidance of $275 million exceeds consensus, but softer margins and cash flow make the Q3 print more mixed than positive.
View source ↗ - Newsprnewswire.com·6d ago·Neutral
Axcelis Announces Participation in Upcoming Investor Conference BEVERLY, Mass., Nov. 16, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the UBS Global Technology and AI Conference taking place November 30 – December 3, 2026 at the Phoenician Hotel, Scottsdale, AZ.
View source ↗ - Newsseekingalpha.com·17d ago·Neutral
Axcelis Technologies, Inc. (ACLS) Q3 2026 Earnings Call Transcript Axcelis Technologies, Inc. ( ACLS ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants David Ryzhik - Interim CFO & Senior VP of Investor Relations and Corporate Strategy Russell Low - CEO, President & Director Conference Call Participants Christian Schwab - Craig-Hallum Capital Group LLC, Research Division Jonathan Dorsheimer - William Blair & Company L.L.C., Research Division Craig Ellis - B.
View source ↗ - Newsmarketbeat.com·17d ago·Neutral
What Axcelis Technologies (ACLS) Said on Its Q3 Earnings Call Axcelis Technologies NASDAQ: ACLS reported third-quarter 2026 revenue of $238 million and earnings per diluted share of $1.26, exceeding its expectations as demand improved across several semiconductor equipment markets.
View source ↗ - Newszacks.com·17d ago·Positive
Axcelis Technologies (ACLS) Tops Q3 Earnings and Revenue Estimates Axcelis Technologies (ACLS) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.21 per share a year ago.
View source ↗ - Newsprnewswire.com·20d ago·Negative
Axcelis Technologies and Veeco Instruments Provide Update on Expected Timing of Merger Closing Merger now expected to close by the end of the first quarter of 2027 BEVERLY, Mass., and PLAINVIEW, N.Y.
View source ↗ - Newszacks.com·24d ago·Neutral
Axcelis Technologies (ACLS) Dips More Than Broader Market: What You Should Know Axcelis Technologies (ACLS) closed at $112.02 in the latest trading session, marking a -1.5% move from the prior day.
View source ↗ - Newsprnewswire.com·26d ago·Neutral
Axcelis Technologies Names Jeroen Delsman as Executive Vice President and Chief Financial Officer BEVERLY, Mass., Oct. 27, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced the appointment of Jeroen Delsman as Executive Vice President and Chief Financial Officer effective November 12, 2026.
View source ↗ - Newszacks.com·30d ago·Neutral
Axcelis Technologies (ACLS) Rises As Market Takes a Dip: Key Facts The latest trading day saw Axcelis Technologies (ACLS) settling at $106.58, representing a +1.76% change from its previous close.
View source ↗ - Newsprnewswire.com·32d ago·Neutral
Axcelis Announces Timing and Availability of Third Quarter 2026 Results and Conference Call BEVERLY, Mass., Oct. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will release financial results for the third quarter of 2026 before the opening of the market on Thursday, November 5, 2026.
View source ↗ - Newszacks.com·37d ago·Neutral
Axcelis Technologies (ACLS) Dips More Than Broader Market: What You Should Know In the most recent trading session, Axcelis Technologies (ACLS) closed at $108.35, indicating a -5.87% shift from the previous trading day.
View source ↗ - Newszacks.com·48d ago·Negative
Axcelis Technologies (ACLS) Stock Slides as Market Rises: Facts to Know Before You Trade In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $142.31, denoting a -3.69% move from the preceding trading day.
View source ↗ - Newsprnewswire.com·62d ago·Neutral
…rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.
View source ↗ - Newszacks.com·67d ago·Neutral
Axcelis Technologies (ACLS) Sees a More Significant Dip Than Broader Market: Some Facts to Know Axcelis Technologies (ACLS) concluded the recent trading session at $103.75, signifying a -1.23% move from its prior day's close.
View source ↗ - Newszacks.com·67d ago·Negative
ACLS Falls 22.4% in Past Month as Recovery Meets Fresh Margin Pressure Axcelis shares fell 22.4% in a month as recovering bookings and demand collide with weaker margins, backlog pressure and heavy China exposure.
View source ↗ - Newszacks.com·67d ago·Neutral
ACLS Invests $35M in Korea To Expand Its Manufacturing Infrastructure Axcelis plans a $35M South Korea ion implantation facility to expand Asian capacity as memory, power and mature-node activity improves.
View source ↗ - Newszacks.com·67d ago·Positive
Should Investors Buy ACLS as Growth Returns Despite Premium Valuation? Axcelis growth is returning as memory, power and aftermarket demand improve, but premium valuation and incomplete margin recovery keep execution in focus.
View source ↗ - Newsprnewswire.com·69d ago·Neutral
…he 25th International Conference on Ion Implantation and Annealing Technology 2026 BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria.
View source ↗ - Newsgurufocus.com·74d ago·Negative
Axcelis Technologies Inc (ACLS) Shares Fall 3.0% -- GF Value Says Still Overvalued On September 09, 2026, Axcelis Technologies Inc (ACLS) shares fell 3.0%, closing at $115.56. The stock has experienced volatility over the past year, with a 52-
View source ↗ - Newszacks.com·74d ago·Neutral
Axcelis Technologies (ACLS) Declines More Than Market: Some Information for Investors Axcelis Technologies (ACLS) closed the most recent trading day at $115.56, moving 3.03% from the previous trading session.
View source ↗ - Newszacks.com·89d ago·Negative
Is the Options Market Predicting a Spike in Axcelis Technologies Stock? Investors need to pay close attention to ACLS stock based on the movements in the options market lately.
View source ↗ - Newsfool.com·93d ago·Positive
Is Axcelis Stock a Buy? Business is accelerating at the perfect moment.
View source ↗ - Newsgurufocus.com·96d ago·Neutral
Axcelis Technologies Inc (ACLS) Shares Fall 5.9% -- What GF Score of 91 Tells Investors On August 18, 2026, Axcelis Technologies Inc (ACLS) shares fell 5.9%, bringing the current price to $135.36. Over the past year, the stock has seen a high of $1
View source ↗
Earnings
Tue, Feb 16(in 3 months)
Consensus estimate $1.51 per share
Typical surprise +19.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 5$1.26 vs $1.11beat
- Thu, Aug 6$1.06 vs $0.89beat
- Thu, May 7$0.72 vs $0.71beat
- Tue, Feb 17$1.49 vs $1.12beat
- Tue, Nov 4$1.21 vs $1.01beat
- Tue, Aug 5$1.13 vs $0.73beat
Estimates and results for ACLS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ACLS officers and directors.
- Bought
- —
- Sold
- $6.3m
0 trades
23 trades
- Sayiner Necipsold
- Sutton Toddsold
- St Dennis Thomassold
- Evans Eileensold
- Blumenstock Gerald Msold
- Tatnall Christophersold
- Graves Gregory Bsold
- Graves Gregory Bsold
77 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ACLS.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
